Condition: Castleman Disease · Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
The study is a pilot, observational, retrospective, and (italian) multicenter study. The study will involve the collection of patient data from medical records for patients with Multicentric Castelman Disease Relapsed/Refractory who received treatment with at least one dose of siltuximab, as part of standard of care in a real-life context, from July 2016 till April 2022 in 31selected italian centres.
This description comes directly from the study's public registry record.
Pier Luigi Zinzani, MD · +390512144042 · pierluigi.zinzani@unibo.it
Beatrice Casadei, MD · +39 0512143680 · beatrice.casadei@aosp.bo.it
Always discuss trial participation with your own doctor first.
| IRCCS Azienda Ospedaliero - Universitaria di Bologna | Bologna, Bologna, Italy | Recruiting |
| Azienda Ospedaliera Sant'Anna e San Sebastiano | Caserta, Caserta, Italy | Recruiting |
| Policlinico di Bari - Azienda Ospedaliero Universitaria Consorziale Policlinico | Bari, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Arcispedale Sant'Anna | Ferrara, Italy | Recruiting |
| Azienda Ospedaliero Universitaria Careggi | Florence, Italy | Recruiting |
| Irccs Ospedale San Raffaele | Milan, Italy | Recruiting |
| Azienda Ospedaliero-Universitaria "Maggiore della Carità" | Novara, Italy | Recruiting |
| Azienda Ospedaliera Di Padova | Padova, Italy | Recruiting |
| Fondazione IRCCS Policlinico San Matteo | Pavia, Italy | Recruiting |
| Azienda Ospedaliera Universitaria Senese | Siena, Italy | Recruiting |
| Azienda ULSS 2 Marca Trevigiana - UOC Medicina Interna 1 Centro di Riferimento per le Malattie Rare del Sistema Immunitario e dell'Apparato Respiratorio | Treviso, Italy | Recruiting |
| Azienda Ulss 2 Marca Trevigiana- Ospedale Di Treviso | Treviso, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06720870